Macular thickness in healthy subjects and diabetics without diabetic macular edema

Mousa, Mohammad Hussein; Ismail, Ali Mahmoud; Elhawwary, Ashraf; Shawky, Seham

doi:10.21608/smj.2017.40747

Macular thickness in healthy subjects and diabetics without diabetic macular edema

Document Type : Original Article

Authors

¹ Department of ophthalmology, Sohag faculty of medicine, Sohag University, Sohag

² Department of Ophthalmology, Faculty of Medicine, Sohag University.

³ epartment of ophthalmology, Sohag faculty of medicine, Sohag University, Sohag

10.21608/smj.2017.40747

Abstract

Purpose: To compare macular thickness values in normal subjects and diabetic patients without diabetic macular edema (DME) using optical coherence tomography (OCT).

Methods :comparative prospective case control study was conducted on 150 eyes with varying stages of diabetic retinopathy compared with 50 normal control.
We used the Topcon,3D OCT-2000 machine to perform the fast macular scan which gives 3 concentric circles : 1 , 3 and 5 mm. centered on the fovea . The mean ± standard deviation of macular thickness by area in these eyes were analyzed and compared.

Results: OCT findings demonstrated that the macula in the diabetic patients with no diabetic retinopathy group was significantly thinner than that of the control group with mean (233.34±29.15) and (221.38±24.26) respectively.
In addition, our findings showed that the macular thickness with mean (221.38±24.26) ,(231.30±29.34) and (256.48 ±39.62)gradually increased with the duration of DM with mean (5.48±4.39) ,(13.96±4.93) and (14.70±4.17) respectively probably because of an increase in vascular permeability in the diabetic retinas .

Conclusion: OCT will allow the detection of early changes and designing a personalized, noninvasive treatment .the role of neurodegeneration in the pathogenesis of DR is a solid basis for proposing neuroprotection as an effective strategy for preventing or arresting DR.

Keywords

References

Al-Nozha MM, Al-Maatouq MA, Al-Mazrou YY, et al. Diabetes mellitus in Saudi Arabia. Saudi Med J. 2004;25:1603–10.

2 - Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649–56.

3 - Esteves J, da Rosa CM, Kramer CK. Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: Case presentation. Diabetol Metab Syndr. 2009;1:13.

4 - Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity: measurements in patients with cystoid macular edema. Ophthalmology. 1987;94:1134-1139.

5 - Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.

6 - Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-332.

7 - Puliafi to CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102:217-229.

8 - Hee MR, Puliafi to CA, Wong C, et al. Optical coherence tomography of central serous chorioretinopathy. Am J Ophthalmol. 1995;120:65-74.

9 - Verma A, Raman R, Vaitheeswaran K, Pal SS, et al. Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy Ophthalmic Res. 2012;47:202–7.

10- GoebelW, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002; 22: 759–767.

11 - Lattanzio R, Brancato R, Pierro L,et al. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients. Eur J Ophthalmol 2002; 12: 482–487.

12 - Sugimoto M, Sasoh M, Ido M, et al. Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy. Ophthalmologica 2005; 219:379–385.